Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: Phase III trial of the Cancer and Leukemia Group B (CALGB 80303) Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Combined Chemotherapy Protocols
  • Deoxycytidine

abstract

  • The addition of bevacizumab to gemcitabine does not improve survival in advanced pancreatic cancer patients.

publication date

  • August 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2917317

Digital Object Identifier (DOI)

  • 10.1200/JCO.2010.28.1386

PubMed ID

  • 20606091

Additional Document Info

start page

  • 3617

end page

  • 22

volume

  • 28

number

  • 22